The trial has a few different sponsors, but I think its primarily being sponsored by John Hopkins Kimmel Center. Roche has at least two other trials in the pancreatic area, in collaboration with the NCI. Each of these trials has begun a various times within the past couple of years. - I do not know when the results are due. CEO of Curis has said he expects data in some of these trials in the second half of this year. Vismodegib has something like 20 trials going on right now in various indications.